Material Agreements

AssetMark Financial Holdings, Inc. entered into Agreement and Plan of Merger with GTCR Everest Borrower, LLC valued at $35.25 per share in cash (effective 2024-04-25).

“AssetMark Financial Holdings, Inc., a Delaware corporation (the " Company "), entered into an Agreement and Plan of Merger (the " Merger Agreement ") by and among the Company, GTCR Everest Borrower, LLC, a Delaware limited liability company (" Parent "), and GTCR Everest Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (" Merger Sub "), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the " Merger ").”

Cosmos Health Inc. entered into Rights Agreement with Globex Transfer, LLC (effective 2024-04-22).

“On April 22, 2024, Cosmos Health Inc. (the “Company”) entered into a Rights Agreement (the “Rights Agreement”), by and between the Company and Globex Transfer, LLC, as Rights Agent”

Netcapital Inc. entered into Riss Purchase Agreement with Paul Riss valued at $58,524 (effective 2024-04-24).

“On April 24, 2024, the Company entered into a Stock Purchase Agreement (the “ Riss Purchase Agreement ”) with Paul Riss, a member of the board of directors of Netcapital Funding Portal, Inc. which is a wholly-owned subsidiary of the Company for the issuance and sale in a private placement (the “ Private Placement ”) of: 442,024 shares (the “ Riss Shares ”) of the Company’s common stock, par value $0.001 per share (“ Common Stock ”), at a price per share of $0.1324 (which price represents the “Minimum Price” under Nasdaq Rule 5635(d)), in consideration of Mr. Riss’ cancellation of $58,524 of outstanding indebtedness owed to him by the Company.”

Netcapital Inc. entered into Geary Purchase Agreement with Steven Geary valued at $31,680 (effective 2024-04-24).

“On April 24, 2024, Netcapital Inc. (the “ Company ”) entered into a Stock Purchase Agreement (the “ Geary Purchase Agreement ”) with Steven Geary, a member of the Company’s board of directors for the issuance and sale in a private placement (the “ Private Placement ”) of: 239,274 shares (the “ Geary Shares ”) of the Company’s common stock, par value $0.001 per share (“ Common Stock ”), at a price per share of $0.1324 (which price represents the “Minimum Price” under Nasdaq Rule 5635(d)), in consideration of Mr. Geary’s cancellation of $31,680 of outstanding indebtedness owed to him by the Company.”

ENERGY FUELS INC entered into Scheme Implementation Deed with Base Resources Limited valued at approximately AUS$375 million (effective 2024-04-21).

“On April 21, 2024, Energy Fuels Inc. (" Energy Fuels "), EFR Australia Pty Ltd, an indirect wholly owned subsidiary of Energy Fuels (" Energy Fuels Bidder "), and Base Resources Limited (" Base Resources ") entered into a Scheme Implementation Deed (the " Deed ") pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, Energy Fuels Bidder will acquire all Base Resources fully paid ordinary shares”

TE Connectivity plc entered into Second Amended and Restated Five-Year Senior Credit Agreement with the lenders party thereto and Bank of America, N.A. valued at $1,500,000,000 (effective 2024-04-24).

“On April 24, 2024, TE Connectivity Ltd. (the “Company”) entered into a Second Amended and Restated Five-Year Senior Credit Agreement (the “Credit Agreement”), by and among the Company, as parent guarantor, its wholly-owned subsidiary, Tyco Electronics Group S.A. (“TEGSA”), as borrower, the lenders party thereto (the “Lenders”) and Bank of America, N.A., as administrative agent, which amends and restates the Five-Year Senior Amended and Restated Credit Agreement, dated as of November 14, 2018 (as amended by the First Amendment to Credit Agreement dated as of June 1, 2021 and the Second Amendment to Credit Agreement dated as of October 14, 2022, the “ Existing Credit Agreement ”), by and among the Company, as parent guarantor, TEGSA, as borrower, the lenders party thereto and Bank of America, N.A., as administrative agent, and which provides for revolving credit commitments in the aggregate amount of $1,500,000,000.”

Great Lakes Dredge & Dock CORP entered into ABL Amendment with PNC Bank, National Association, as agent for the lenders, and certain financial institutions party thereto (effective 2024-04-24).

“On April 24, 2024, the Credit Parties, PNC Bank, National Association (“PNC”), as agent for the lenders, and certain financial institutions party thereto entered into an amendment to the ABL Credit Agreement (the “ABL Ame”

Great Lakes Dredge & Dock CORP entered into Second Lien Credit Agreement with Guggenheim Corporate Funding, LLC, on behalf of one or more clients, as the lender; Guggenheim Credit Services, LLC as Administrative Agent, Collateral Agent and Lead Arranger valued at $150,000,000 (effective 2024-04-24).

“On April 24, 2024, Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”), Great Lakes Dredge & Dock Company, LLC, NASDI Holdings, LLC, Great Lakes Environmental & Infrastructure Solutions, LLC, Great Lakes U.S. Fleet Management, LLC, and Drews Services LLC (collectively with the Company, the “Credit Parties”) entered into a $150,000,000 second lien credit agreement (as amended, supplemented or otherwise modified from time to time, the “Second Lien Credit Agreement”) with Guggenheim Corporate Funding, LLC, on behalf of one or more clients, as the lender, and Guggenheim Credit Services, LLC as Administrative Agent, Collateral Agent and Lead Arranger (“GCS”).”

CME GROUP INC. amended Amendment with Bank of America, N.A., in its capacity as administrative agent, Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, and the banks party thereto valued at $10 billion (effective 2024-04-24).

“On April 24, 2024, Chicago Mercantile Exchange Inc. (“CME”), a wholly owned subsidiary of CME Group Inc., entered into an amendment (the “Amendment”) to its 364-day multi-currency credit facility (the “Existing Credit Facility”) with Bank of America, N.A., in its capacity as administrative agent, Citibank, N.A., in its capacity as collateral agent and collateral monitoring agent, and the banks party thereto.”

TOYOTA AUTO FINANCE RECEIVABLES LLC entered into Underwriting Agreement with SMBC Nikko Securities America, Inc., Barclays Capital Inc., RBC Capital Markets, LLC and U.S. Bancorp Investments, Inc., acting on behalf of themselves and as representatives of the several underwriters named therein valued at $375,000,000; $262,100,000; $357,900,000; $620,000,000; $91,260,000; $43,740,000 (effective 2024-04-23).

“On April 23, 2024, Toyota Auto Finance Receivables LLC (“TAFR LLC”) and Toyota Motor Credit Corporation (“TMCC”) entered into an Underwriting Agreement with SMBC Nikko Securities America, Inc., Barclays Capital Inc., RBC Capital Markets, LLC and U.S. Bancorp Investments, Inc., acting on behalf of themselves and as representatives of the several underwriters named therein, for the sale of certain notes of Toyota Auto Receivables 2024-B Owner Trust”

CARNIVAL PLC entered into Repricing Amendment No. 6 to the Term Loan Agreement dated as of June 30, 2020 with JPMorgan Chase Bank, N.A. valued at reprices approximately $1.75 billion of first-priority senior secured term loans maturing in 2028 to (effective 2024-04-25).

“(y) the Repricing Amendment No. 6 (the “2028 Repricing Amendment”, and together with the 2027 Repricing Amendment, the “Repricing Amendments”) to the Term Loan Agreement dated as of June 30, 2020 (the “2028 Term Loan Credit Agreement”), among the Company and Carnival Finance, LLC, as borrowers, Carnival plc, as a guarantor, certain other subsidiary guarantors party thereto, and JPMorgan Chase Bank, N.A., as administrative agent.”

CARNIVAL PLC entered into Repricing Amendment No. 1 to the Term Loan Agreement dated August 8, 2023 with JPMorgan Chase Bank, N.A. valued at reprices approximately $1 billion of first-priority senior secured term loans maturing in 2027 to be (effective 2024-04-25).

“On April 25, 2024, the Company entered into (x) the Repricing Amendment No. 1 (the “2027 Repricing Amendment”) to the Term Loan Agreement dated August 8, 2023 (the “2027 Term Loan Credit Agreement”), among the Company and Carnival Finance, LLC, as borrowers, Carnival plc, as a guarantor, certain other subsidiary guarantors party thereto, and JPMorgan Chase Bank, N.A., as administrative agent”

CARNIVAL PLC entered into Indenture with U.S. Bank Trust Company, National Association valued at €500 million aggregate principal amount of 5.750% senior unsecured notes due 2030 (effective 2024-04-25).

“On April 25, 2024, Carnival Corporation (the “Company”) closed its previously announced private offering (the “Notes Offering”) of €500 million aggregate principal amount of 5.750% senior unsecured notes due 2030 (the “Notes”). The Notes were issued pursuant to an indenture, dated as of April 25, 2024 (the “Indenture”), among the Company, Carnival plc, the subsidiary guarantors party thereto and U.S. Bank Trust Company, National Association, as trustee.”

Panbela Therapeutics, Inc. entered into Subscription and Investment Representation Agreement with Michael T. Cullen valued at $10 (effective 2024-04-23).

“On April 23, 2024, Panbela Therapeutics, Inc. (the “Company”) entered into a Subscription and Investment Representation Agreement (the “Subscription Agreement”) with Michael T. Cullen (the “Purchaser”), Chairman of the Company’s Board of Directors, pursuant to which the Company agreed to issue and sell one (1) share of the Company’s Series A Preferred Stock, par value $0.001 per share (the “Preferred Stock”), to the Purchaser for $10 cash.”

VSE CORP entered into Seventh Amendment to Fourth Amended and Restated Business Loan and Security Agreement with Citizens Bank, N.A. valued at Amendment provides flexibility for the Company to enter into certain accounts receivables factoring (effective 2024-04-23).

“On April 23, 2024, VSE Corporation (“VSE” or the “Company”) and a majority of its wholly owned subsidiaries, as borrowers, entered into that certain Seventh Amendment (the “Amendment”) to the Fourth Amended and Restated Business Loan and Security Agreement”

HIBBETT INC entered into Agreement and Plan of Merger with Genesis Holdings, Inc., Steps Merger Sub, Inc., and JD Sports Fashion plc valued at $87.50 in cash (effective 2024-04-23).

“On April 23, 2024, Hibbett, Inc., a Delaware corporation (the “ Company ” or “ Hibbett ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among the Company, Genesis Holdings, Inc., an Indiana corporation (“ Parent ”), Steps Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (“ Merger Sub ”)”

GEO GROUP INC entered into 2031 Indenture with Ankura Trust Company, LLC valued at $625.0 million aggregate principal amount of 10.25% senior notes due 2031 (effective 2024-04-18).

“$625.0 million aggregate principal amount of 10.25% senior notes due 2031 (the “Unsecured Notes” and, together with the Secured Notes, the “Notes”), issued under the Indenture, dated as of April 18, 2024 (the “2031 Indenture” and, together with the 2029 Indenture, the “Indentures”), among GEO, the Guarantors and Ankura Trust Company, LLC as Trustee”

GEO GROUP INC entered into 2029 Indenture with Ankura Trust Company, LLC valued at $650.0 million aggregate principal amount of 8.625% senior secured notes due 2029 (effective 2024-04-18).

“On April 18, 2024, The GEO Group, Inc. (“GEO” or the “Company”) announced the closing of its previously announced private offering of $1.275 billion aggregate principal amount of senior notes (the “Senior Notes Offering”), comprised of $650.0 million aggregate principal amount of 8.625% senior secured notes due 2029 (the “Secured Notes”), issued under the Indenture, dated as of April 18, 2024 (the “2029 Indenture”), among GEO, the Guarantors (defined below) and Ankura Trust Company, LLC, as trustee and collateral agent”

VAIL RESORTS INC amended Ninth A&R Credit Agreement with Bank of America, N.A., as administrative agent, and certain Lenders (effective 2024-04-24).

“On April 24, 2024, Vail Holdings, Inc., a Colorado corporation (the “Borrower”) and a wholly-owned subsidiary of Vail Resorts, Inc. (the “Company”), a Delaware corporation, certain subsidiaries of the Company and the Company, as guarantors, Bank of America, N.A., as administrative agent, and certain Lenders entered into an amendment and restatement of the Eighth Amended and Restated Credit Agreement, dated as of August 15, 2018 (as so amended and restated, the “Ninth A&R Credit Agreement”).”

Israel Acquisitions Corp amended Business Combination Agreement with Pomvom Ltd. (effective 2024-04-22).

“On April 22, 2024, the Company and Pomvom entered into an amendment (the “Amendment”) to the Business Combination Agreement.”

Screaming Eagle Acquisition Corp. entered into Non-Redemption Agreements with Non-Redemption Investors valued at approximately $20 million (effective 2024-04-24).

“On April 24, 2024, SEAC and Pubco entered into share purchase and non-redemption agreements (the "Non-Redemption Agreements") with the Non-Redemption Investors. Pursuant to the Non-Redemption Agreements, among other things, the Non-Redemption Investors agreed to: (i) certify that they had purchased an aggregate of approximately $20 million of Class A ordinary shares”

Cyngn Inc. entered into Underwriting Agreement with Aegis Capital Corp. valued at $5 million (effective 2024-04-23).

“On April 23, 2024, Cyngn Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (the “Underwriter”), in connection with a firm commitment underwritten public offering”

Mountain Crest Acquisition Corp. V entered into Note Conversion Agreement with Mountain Crest Global Holdings LLC valued at $600,000 (effective 2024-04-19).

“On April 19, 2024, as approved by the Company’s audit committee, the Company entered into a note conversion agreement (the “Note Conversion Agreement”) with the Sponsor, to convert the Principal Amount due under the Notes into 150,000 shares of the Company’s common stock”

GCT Semiconductor Holding, Inc. entered into Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC valued at $50,000,000 (effective 2024-04-23).

“On April 23, 2024, GCT Semiconductor Holding, Inc. (the “Company”) entered into a Common Stock Purchase Agreement (the “Purchase Agreement”) and a related Registration Rights Agreement (the “Registration Rights Agreement”) with B. Riley Principal Capital II, LLC (“B. Riley Principal Capital II”).”

Centessa Pharmaceuticals plc entered into "Underwriting Agreement" with Goldman Sachs & Co. LLC and Leerink Partners LLC, as representatives of the underwriters named therein (effective 2024-04-23).

“On April 23, 2024, Centessa Pharmaceuticals plc (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC and Leerink Partners LLC, as representatives (the “Representatives”) of the underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of 10,810,810 American Depositary Shares (the “ADSs”), each presenting one ordinary share, with a nominal value £0.002 per share (the “Ordinary Share”), of the Company (the “Firm ADSs”), at a price to the public of $9.25 per ADS (the “Offering”).”

Stardust Power Inc. amended Amendment with Global Partner Acquisition Corp II, Strike Merger Sub I, Inc., Strike Merger Sub II, LLC (effective 2024-04-24).

“On April 24, 2024, Global Partner Acquisition Corp II, a Cayman Islands exempted company (“GPAC II”), Strike Merger Sub I, Inc., a Delaware corporation and direct wholly-owned subsidiary of GPAC II, Strike Merger Sub II, LLC, a Delaware limited liability company and direct wholly-owned subsidiary of GPAC II, and Stardust Power Inc., a Delaware corporation (“Stardust Power”), entered into Amendment No. 1 (the “Amendment”) to that certain Business Combination Agreement, dated November 21, 2023”

Third Coast Bancshares, Inc. amended Renewal, Extension and Modification of Loan with American National Bank & Trust valued at increases the maximum commitment under the Loan Agreement from $50,000,000 to $55,000,000 (effective 2024-03-12).

“Effective March 12, 2024 (the “Effective Date”), Third Coast Bancshares, Inc. (the “Company”) entered into a Renewal, Extension and Modification of Loan (the “Amendment”) of the Loan Agreement, dated March 10, 2021, by and between the Company and American National Bank & Trust (the “Loan Agreement”).”

Great Elm Capital Corp. entered into Amended and Restated Limited Liability Company Agreement with Green SPE, LLC (effective 2024-04-23).

“On April 23, 2024, Great Elm Capital Corp. (the “Company”), Green SPE, LLC (“Green”) and CLO Formation JV, LLC (the “JV”) entered into an Amended and Restated Limited Liability Company Agreement (the “LLC Agreement”) of the JV, pursuant to which the Company owns 75% of the membership interests in the JV and Green owns 25% of the membership interests in the JV.”

Loop Media, Inc. entered into Non-Revolving Line of Credit Loan Agreement with Lenders and RAT Investment Holdings, LP, as Loan Administrator valued at aggregate loans of up to $2.2 million (effective 2022-05-13).

“effective as of May 13, 2022, Loop Media, Inc. (the “ Company ”) entered into a Non-Revolving Line of Credit Loan Agreement (the “ Loan Agreement ”) with several institutions and individuals (each individually a “ Lender ” and collectively, the “ Lenders ”) and RAT Investment Holdings, LP, as administrator of the loan (the “ Loan Administrator ”) for aggregate loans of up to $2.2 million (the “ Line of Credit ”)”

Loop Media, Inc. amended Non-Revolving Line of Credit Loan Agreement Amendment #2 with Lenders and RAT Investment Holdings, LP, as Loan Administrator valued at extended maturity to January 13, 2025; amended payment terms (effective 2024-04-18).

“On April 18, 2024, the Company entered into a Non-Revolving Line of Credit Loan Agreement Amendment #2 (the “ Loan Agreement Amendment #2 ”) with the Lenders to: (i) extend the Original Line of Credit Maturity Date from eighteen (18) months to thirty-two (32) months from the date of the Loan Agreement, or January 13, 2025 (the “ Second Extended Line of Credit Maturity Date ”); and (ii) amend the payment terms of the Line of Credit such that payments of interest and principal under the Loan Agreement and the Note will be due and payable from April 13, 2024, to the Second Extended Line of Credit Maturity Date, as follows: (a) one payment of $121,000, comprised of accrued interest of $11,000 through April 13, 2024, and an initial payment of principal of $110,000, due on April 13, 2024; and (b) nine (9) monthly payments of principal of $110,000, plus accrued interest, commencing May 13, 2024.”

Grom Social Enterprises, Inc. amended April 2024 Note Amendment with Generating Alpha Ltd. (effective 2024-04-24).

“In connection with the April 2024 SPA Amendment, the Company entered into an amendment (the “ April 2024 Note Amendment ”) to the convertible promissory note dated April 4, 2024 issued to the Investor in connection with the April 2024 SPA (as amended on April 24, 2024, the “ April 2024 Note ”) with the Investor pursuant to which in no event shall the conversion price be less than $0.17.”

Grom Social Enterprises, Inc. amended April 2024 SPA Amendment with Generating Alpha Ltd. (effective 2024-04-24).

“On April 24, 2024, the Company entered into a first amendment agreement (the “ April 2024 SPA Amendment ”) to the securities purchase agreement dated April 1, 2024 (as amended on April 24, 2024, the “ April 2024 SPA ”) with the Investor pursuant to which the Company shall promptly effect a reverse stock split in the event that the closing price of Common Stock falls below $0.25 per share for a period of five consecutive trading days.”

Grom Social Enterprises, Inc. amended Omnibus Amendment Agreement with Generating Alpha Ltd. (effective 2024-04-24).

“On April 24, 2024, Grom Social Enterprises, Inc., a Florida corporation (the “ Company ”), entered into an omnibus amendment agreement (the “ Omnibus Amendment Agreement ”) with Generating Alpha Ltd., a Saint Kitts and Nevis Corporation (the “ Investor ”).”

HEALTHY EXTRACTS INC. terminated Acquisition Agreement with Hyperion, L.L.C. and Online Publishing & Marketing, LLC valued at Termination of Acquisition Agreement (effective 2024-04-18).

“On January 13, 2023, we entered into an Acquisition Agreement for the acquisition of Hyperion, L.L.C. and Online Publishing & Marketing, LLC, both Virginia limited liabilities companies, by merging them into our newly-formed wholly-owned subsidiaries, Green Valley Natural Solutions, LLC (“Green Valley”) and Online Publishing & Marketing, LLC (“OPM”), both Nevada limited liability companies. We have not completed the acquisitions, and on April 18, 2024, we received a Notice of Termination of the Acquisition Agreement from both Hyperion, L.L.C. and Online Publishing & Marketing, LLC.”

Cidara Therapeutics, Inc. terminated 2021 Collaboration Agreement with Janssen Pharmaceuticals, Inc. valued at Terminated upon effectiveness of the Janssen License Agreement (effective 2024-04-24).

“Upon the effectiveness of the Janssen License Agreement, the 2021 Collaboration Agreement, including the license granted by the Company to Janssen and the Company’s non‐compete covenant thereunder, terminated, and the Company assumed responsibility for further clinical development, manufacture, registration and commercialization of DFCs within the Influenza Program (“Compounds”), including CD388, and products containing Compounds (“Products”), including Products containing CD388 (“CD388 Product”).”

Cidara Therapeutics, Inc. entered into Securities Purchase Agreement with Institutional and other accredited investors valued at 240,000 shares of Series A Convertible Voting Preferred Stock at $1,000 per share for total gross pr (effective 2024-04-23).

“On April 23, 2024 (the “Signing Date”), the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional and other accredited investors (the “Purchasers”), pursuant to which the Company issued and sold, in a private placement (the “Private Placement”), 240,000 shares of Series A Convertible Voting Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), at a purchase price of $1,000 per share.”

Cidara Therapeutics, Inc. entered into License and Technology Transfer Agreement with Janssen Pharmaceuticals, Inc. valued at Upfront payment of $85 million; up to $150 million in development and regulatory milestone payments; (effective 2024-04-24).

“On April 23, 2024 (the “Signing Date”), the Company and Janssen Pharmaceuticals, Inc. (“Janssen”) entered into a license and technology transfer agreement (the “Janssen License Agreement”) related to drug-Fc conjugates (“DFCs”) based on the Company’s Cloudbreak ® platform for the prevention and treatment of influenza (“Influenza Program”), including CD388, the Company’s most advanced DFC program, which has completed a Phase 2a clinical trial.”

Cidara Therapeutics, Inc. terminated Asset Purchase Agreement-related termination with NAPP Pharmaceutical Group Limited valued at Termination of certain material definitive agreements in connection with asset sale; see Item 1.01 (effective 2024-04-24).

“Item 1.02 Termination of a Material Definitive Agreement. See Item 1.01 above, which is incorporated by reference into this Item 1.02.”

Cidara Therapeutics, Inc. amended Melinta License Agreement with Melinta Therapeutics, LLC valued at Modified regulatory milestones payable upon receipt of marketing approval of rezafungin acetate for (effective 2024-04-23).

“In connection with the Purchase Agreement and as a condition to entering into the Purchase Agreement, the Company entered into an amendment, dated April 23, 2024, to the Melinta License Agreement (the "Melinta License Amendment") that, among other changes, modified the regulatory milestones payable upon receipt of marketing approval of the current rezafungin acetate product for an Additional Indication (as defined in the Melinta License Agreement).”

Cidara Therapeutics, Inc. entered into Assignment and Novation Agreement with NAPP Pharmaceutical Group Limited and Mundipharma Medical Company valued at Transfer of Mundipharma Collaboration Agreement and Commercial Supply Agreement from Company to NAPP (effective 2024-04-24).

“The Company, NAPP and Mundipharma also entered into an Assignment and Novation Agreement to transfer the Mundipharma Collaboration Agreement and Commercial Supply Agreement from the Company to NAPP (the "Novation Agreement").”

Cidara Therapeutics, Inc. entered into Asset Purchase Agreement with NAPP Pharmaceutical Group Limited valued at Assumption of liabilities including costs of ReSPECT Phase 3 and ReSTORE Phase 3 clinical trials; fo (effective 2024-04-24).

“On April 24, 2024, the Company and NAPP Pharmaceutical Group Limited, a company organized under the laws of England ("NAPP"), and an affiliate of Mundipharma Medical Company ("Mundipharma"), entered into an Asset Purchase Agreement (the "Purchase Agreement") pursuant to which the Company sold to NAPP, effective as of April 24, 2024, all of the Company's rezafungin acetate assets, including all of the Company's right to receive future milestones and royalties under the License Agreement, dated July 26, 2022 between the Company and Melinta Therapeutics, LLC, as amended, (the "Melinta License Agreement") and the License and Collaboration Agreement dated September 3, 2019 between the Company and Mundipharma, as amended, (the "Mundipharma Collaboration Agreement"), all rezafungin intellectual property rights, including patents and know-how, all product data, regulatory approvals and documentation, rezafungin and comparator inventory, specified prepaid assets and specified contracts, in exch”

STORE CAPITAL LLC entered into Note Purchase Agreement with ATLAS SP Securities, a division of Apollo Global Securities, LLC, Citigroup Global Markets Inc., BofA Securities, Inc., Truist Securities, Inc., Capital One Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Scotia Capital (USA) Inc valued at $450,000,000 aggregate principal amount (effective 2024-04-05).

“On April 18, 2024, STORE Capital LLC, a Delaware limited liability company (the “ Company ”), completed the issuance of $450,000,000 aggregate principal amount of STORE Master Funding Net-Lease Mortgage Notes, Series 2024-1 (the “ Notes ”) by STORE Master Funding I, LLC, STORE Master Funding II, LLC, STORE Master Funding III, LLC, STORE Master Funding IV, LLC, STORE Master Funding V, LLC, STORE Master Funding VI, LLC, STORE Master Funding VII, LLC, STORE Master Funding XIV, LLC, STORE Master Funding XIX, LLC, STORE Master Funding XX, LLC, STORE Master Funding XXII, LLC and STORE Master Funding XXIV, LLC (together, the “ Issuers ”).”

VERDE RESOURCES, INC. entered into Services Agreements with Dr. Nam Tran and Dr. Raymond Powell valued at 3,000,000 shares of the Company’s restricted common stock (effective 2024-04-20).

“On April 20, 2024, Verde Resources, Inc. (the “Company”) entered into two Services Agreements (the “Agreements”) with Dr. Nam Tran and Dr. Raymond Powell”

Vita Coco Company, Inc. entered into Co-Manufacturing and Purchasing Agreement with Axelum Resources Corp. (effective 2024-04-18).

“On April 18, 2024, All Market Singapore PTE Ltd., a wholly owned subsidiary of The Vita Coco Company, Inc. (the “Company”), entered into a Co-Manufacturing and Purchasing Agreement (the “Manufacturing Agreement”) with Axelum Resources Corp. (“Axelum”).”

KINETA, INC./DE entered into settlement agreement and mutual release with RLB Holdings Connecticut, LLC valued at $500,000 (effective 2024-04-22).

“On April 22, 2024, Kineta, Inc. (the “Company”) entered into a settlement agreement and mutual release (the “Agreement”) by and between the Company and RLB Holdings Connecticut, LLC (“RLB”) to continue RLB’s investment in the Company and to resolve any and all potential claims or causes of action in connection with RLB’s failure to purchase $2,500,000 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), pursuant to a financing agreement, dated as of June 5, 2022, as amended on October 24, 2022, December 5, 2022, March 29, 2023, May 1, 2023, July 21, 2023 and October 13, 2023.”

ORION ENERGY SYSTEMS, INC. amended Amendment No. 2 with Bank of America, N.A. valued at $3.525 million (effective 2024-04-22).

“Effective April 22, 2024, Orion Energy Systems, Inc. (the “Company”), with Bank of America, N.A. as lender, executed Amendment No. 2 (“Amendment No. 2”) to its Loan and Security Agreement dated December 29, 2020 and amended previously on November 4, 2022 (the “LSA”).”

Venus Concept Inc. entered into Loan and Security Agreement with Madryn Health Partners, LP valued at $2,237,906.85 (effective 2024-04-23).

“On April 23, 2024, Venus Concept Inc. (the “Company”) entered into a Loan and Security Agreement (the “Loan and Security Agreement”), by and among Venus Concept USA Inc. (the “Borrower”), Venus Concept Canada Corp. (“Venus Canada”), Venus Concept Ltd. (“Venus Israel”, and together with the Company and Venus Canada, the “Guarantors,” and together with the Borrower, the “Loan Parties”), each lender party thereto (collectively, the “Lenders”) and Madryn Health Partners, LP, as administrative agent (“Madryn”).”

SANTANDER DRIVE AUTO RECEIVABLES LLC entered into Underwriting Agreement with Santander Consumer USA Inc., Santander Drive Auto Receivables LLC, and Barclays Capital Inc. (representative of underwriters) valued at sale of Publicly Registered Notes to Underwriters: Barclays Capital Inc., Santander US Capital Marke (effective 2024-04-16).

“The Publicly Registered Notes were sold to Barclays Capital Inc., Santander US Capital Markets LLC, Wells Fargo Securities, LLC, Academy Securities, Inc. and Samuel A. Ramirez & Company, Inc. (together, the “Underwriters”), pursuant to an Underwriting Agreement, dated as of April 16, 2024, by and among SC, Santander Drive and Barclays Capital Inc., on behalf of itself and as representative of the Underwriters.”

SANTANDER DRIVE AUTO RECEIVABLES LLC entered into Administration Agreement with Santander Consumer USA Inc. and Wilmington Trust, National Association valued at provision by SC of certain administration services on behalf of the Issuer relating to the Notes (effective 2024-04-24).

“On the Closing Date, the Issuer, SC, as administrator, and the Indenture Trustee entered into an Administration Agreement, dated as of the Closing Date (the “Administration Agreement”), relating to the provision by SC of certain administration services on behalf of the Issuer relating to the Notes.”

SANTANDER DRIVE AUTO RECEIVABLES LLC entered into Indenture with Santander Drive Auto Receivables Trust 2024-2 and Wilmington Trust, National Association valued at Issuance of Class A-2 5.80%, A-3 5.63%, B 5.78%, C 5.84%, D 6.28% Auto Loan Asset Backed Notes (Publ (effective 2024-04-24).

“On the Closing Date, the Issuer entered into an Indenture, dated as of the Closing Date (the “Indenture”), by and between the Issuer and the Indenture Trustee. Pursuant to the Indenture, the Issuer caused the issuance of the following notes: the Class A-2 5.80% Auto Loan Asset Backed Notes, the Class A-3 5.63% Auto Loan Asset Backed Notes, the Class B 5.78% Auto Loan Asset Backed Notes, the Class C 5.84% Auto Loan Asset Backed Notes and the Class D 6.28% Auto Loan Asset Backed Notes (collectively, the “Publicly Registered Notes”) and the Class A-1 5.598% Auto Loan Asset Backed Notes (the “Retained Notes” and together with the Publicly Registered Notes, the “Notes”).”